First Horizon Advisors’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-45
Closed -$3.62K 2312
2024
Q3
$3.62K Hold
45
﹤0.01% 1881
2024
Q2
$3.72K Buy
45
+19
+73% +$1.67K ﹤0.01% 1832
2024
Q1
$2.22K Hold
26
﹤0.01% 2007
2023
Q4
$2.22K Hold
26
﹤0.01% 2001
2023
Q3
$2.33K Hold
26
﹤0.01% 1942
2023
Q2
$2.21K Hold
26
﹤0.01% 2043
2023
Q1
$2.15K Hold
26
﹤0.01% 2075
2022
Q4
$2.04K Hold
26
﹤0.01% 2059
2022
Q3
$1K Hold
26
﹤0.01% 2124
2022
Q2
$1K Buy
+26
New +$1.54K ﹤0.01% 2211
2022
Q1
Sell
-26
Closed -$1K 1954
2021
Q4
$1K Hold
26
﹤0.01% 2108
2021
Q3
$1K Hold
26
﹤0.01% 2123
2021
Q2
$1K Hold
26
﹤0.01% 1872
2021
Q1
$2K Sell
26
-136
-84% -$16.8K ﹤0.01% 1657
2020
Q4
$19K Sell
162
-7
-4% -$754 ﹤0.01% 900
2020
Q3
$14K Hold
169
﹤0.01% 929
2020
Q2
$15K Buy
+169
New +$17.1K ﹤0.01% 890
2016
Q2
Sell
-31
Closed 1358
2016
Q1
$0 Hold
31
﹤0.01% 1353
2015
Q4
$0 Sell
31
-195
-86% -$6.33K ﹤0.01% 1308
2015
Q3
$7K Sell
226
-45
-17% -$1.69K ﹤0.01% 1085
2015
Q2
$11K Sell
271
-51
-16% -$2.15K ﹤0.01% 1001
2015
Q1
$14K Sell
322
-114
-26% -$4.77K ﹤0.01% 948
2014
Q4
$16K Sell
436
-65
-13% -$2.38K ﹤0.01% 894
2014
Q3
$17K Buy
501
+243
+94% +$8.67K ﹤0.01% 882
2014
Q2
$9K Buy
258
+207
+406% +$6.92K ﹤0.01% 1068
2014
Q1
$1K Buy
+51
New +$1.95K ﹤0.01% 1288

Other funds holding HAE

First Horizon Advisors's HAE Position: Q4 2024 in Review

First Horizon Advisors sold out of Haemonetics (HAE) in Q4 2024, closing a stake of 45 shares — an estimated $3.62K sold.

First Horizon Advisors first reported a position in HAE in Q1 2014 and held it in 26 quarters. The position peaked at $19K in Q4 2020. 309 funds tracked by Wall St. Rank hold HAE as of Q4 2024.

  • First Horizon Advisors reported no remaining Haemonetics position as of Q4 2024 after selling out during the quarter.
  • First Horizon Advisors sold 45 Haemonetics shares in Q4 2024, an estimated $3.62K.
  • First Horizon Advisors first reported a position in Haemonetics in Q1 2014 and held it in 26 quarters.
  • First Horizon Advisors's Haemonetics position peaked at $19K in Q4 2020.
  • 309 funds tracked by Wall St. Rank held Haemonetics as of Q4 2024.

Based on First Horizon Advisors's 13F filing for Q4 2024, filed 3 Feb 2025.